Pegasus Capital
VC Fund
Cos Cob, United States
Pegasus Capital is a VC fund in Cos Cob focused on Biotechnology and Solar. Pegasus Capital Advisors, L.P. is a U.S.-based private equity fund manager that provides creative capital and business solutions to middle market companies across a wide variety of industries.Established in 1995, Pegasus currently manages over $1.8 billion in assets through several private equity funds and has made more than 70 investmentssince its inception. The firm employs over 50 uniquely talented investment and advisory professionals in main offices in Cos Cob, CT, New York, NY, as well as several satellite locations.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $28M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Pegasus Capital invests in
Stages Pegasus Capital invests in
Countries Pegasus Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Round size
- Series A
- $2M–$30M
- Private Equity
- $43M–$53M
Investment Focus
Industry
- Biotechnology 3 (27%)
- Solar 2 (18%)
- Software 2 (18%)
- Health Care 2 (18%)
- Manufacturing 2 (18%)
Stage
- Series A 4 (36%)
- Private Equity 2 (18%)
- Seed 1 (9%)
- Series B 1 (9%)
- Series D 1 (9%)
Country
- United States 8 (73%)
- China 1 (9%)
- Mexico 1 (9%)
- United Arab Emirates 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alan Libshutz
Operating partner
|
Operating partner | Total investments: 0 | Find email | |
Craig Cogut
Founder and CEO
|
Founder and CEO | Total investments: 2 | Find email | |
David Bell
CEO
|
CEO | Total investments: 2 | Find email | |
David Cogut
Co-managing Partner
|
Co-managing Partner | Total investments: 1 | Find email | |
Gabriel Miller
Operating partner
|
Operating partner | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Evotrex focused on changing outdoor travel and adventure by introducing clever, power-generating RV trailers geared for self-sufficiency and off-grid exploration. | $30M / Series A / Jun 09, 2026 | ||
| Seaweed provides a sustainable and regenerative platform to address CO2 sequestration, pollution and volatility from our climate emergency. Our systems-level approach means that every part of our operation - from collection to distribution - is geared at restoring vital ecosystems and supporting resilient circular economies. | $6M / Jun 23, 2023 | ||
| A leading Mexican renewable energy company that offers turn-key solar energy installations for businesses and enterprises without up-front investments, through a Power Purchase Agreement (PPA) and leasing models. LUXUN aims to eliminate financial and operational barriers to solar energy adoption while taking advantage of the country's vastsolar irradiance, reducing reliance on fossil fuels, and avoiding harmful emissions. | $43M / Private Equity / May 17, 2023 | ||
| Qiangsi Digital is a digital twin company with core technology and products focusing on the digital transformation of the process industry. They provide services that include design, construction, delivery, operation, and optimization. An online inquiry form is available on the company's website. | Series A / Sep 30, 2022 | ||
| Phase Change Solutions (PCS) is a global leader in the development and supply of phase change materials (“PCMs”). The company’s proprietary family of PCMs, collectively referred to as BioPCM®, has been certified with 100% bio-based content and listed among the USDA Biopreferred products. BioPCM® can be designed to store and release thermal energyat temperatures ranging from -75°C to 175°C. This tuning capability enables customers worldwide to use BioPCM® to reach their sustainable development goals (SDGs). Since its founding in 2011, PCS has helped maintain optimum temperatures and save energy in a range of industries: transportation and storage of food, pharmaceuticals, and perishables; buildings and structures; and telecom and data centers.The company continues to be recognized globally for its scientific achievements, innovative products, and approach to sustainability. PCS was most recently selected as one of nine companies in the inaugural cohort of The Clean Fight New York. PCS was also recognized as a 2020 Global Cleantech 100 company and one of ten Bloomberg BNEF Global Pioneer award winners for 2020. Join PCS on this journey to create a sustainable future. | Series B / Jan 22, 2019 | ||
| Permission based employment and income verification for the gig-economy. | $6M / Seed / Jun 01, 2016 | ||
| PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and the commercialization of its products that both address the specificdietary needs of children with infectious diarrhea, and support overall intestinal health.The company’s medical nutrition products are regulated in three FDA categories: medical foods, food for special dietary use, and dietary supplements.PanTheryx was founded in 2007 by Mark A. Braman and is based in Boulder, Colorado. | $53M / Private Equity / Mar 30, 2016 | ||
| PropertyFinder owns and operates real estate portals across Dubai. Available in both English and Arabic, its websites provide visitors with search facilities covering residential and commercial properties for rent or for sale, real estate news, home advice, and buying and selling guides.PropertyFinder provides its users with the tools to helpconsumers find the properties that fit their needs. It works with brokers to list properties in one convenient site, and make it easier to see all of the information about those properties while browsing from its users’ desktop or on the move. | $2M / Series A / Feb 01, 2013 | ||
| Apellis Pharmaceuticals is an early-stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease. The company is leveraging courageous science, creativity, andcompassion to deliver life-changing medicines. They aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. | $3M / Series A / Jun 20, 2011 | ||
| Core Security provides enterprises with market-leading, threat-aware, identity, access and vulnerability management solutions that enable actionable intelligence. | $6.5M / Series D / Oct 17, 2008 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pegasus Capital invest in?
Pegasus Capital invests primarily in Biotechnology, Solar and Software startups, most often at Series A and Private Equity stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Pegasus Capital invest in?
Pegasus Capital typically joins rounds of $2M–$30M at Series A and $43M–$53M at Private Equity. These are whole funding-round sizes, not Pegasus Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Pegasus Capital took part in.
How do I contact Pegasus Capital?
Public channels for Pegasus Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pegasus Capital?
The team at Pegasus Capital includes Alan Libshutz (Operating partner), Craig Cogut (Founder and CEO) and David Bell (CEO), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
